apotheke.de
Medikamente, Kosmetik uvm. mit bis zu 60% Ersparnis ✓ Rezepte einfach & schnell online einlösen ✓ große Auswahl ✓ schnelle Lieferung
GRIPS CUSTOMERS & RESEARCH PARTNERS
apotheke.de's monthly revenueOVER TIME
Over the past three months, apotheke.de revenue has experienced growth of 35%, compared to the preceding three months.
apotheke.de competitors
In September 2025, apotheke.de generated a revenue of 1,000,629 with 6,219 transactions and 122,191 sessions, boasting an average order value (AOV) of 150-175 and a conversion rate of 5.00-5.50. Comparing this data to its competitors, apodiscounter.de had a significantly higher revenue of 2,891,288 with 46,123 transactions and 1,265,373 sessions, but with a lower AOV of 50-75 and conversion rate of 3.50-4.00. medpex.de outperformed all with a revenue of 16,370,738, 148,130 transactions, and 1,862,631 sessions, along with an AOV of 100-125 and a conversion rate of 7.50-8.00. In terms of AOV and conversion rate, apotheke.de is on par with sparmedo.de, which had a revenue of 208,936, 1,281 transactions, and 38,367 sessions. Overall, while apotheke.de may not have the highest revenue, it holds its own in terms of AOV and conversion rate compared to its competitors.
Revenue share by device at apotheke.de
In September large majority of sales on apotheke.de, 55% was finalized on desktop devices, with 45% of sales coming from mobile devices (mobile web only, excluding app usage, if relevant).
Gain even more insights with the Grips app
apotheke.de channels
Identify top traffic channels that drive growth for apotheke.deand discover how performance of traffic channels has changed over time.
apotheke.de Google Ads spend
Evaluate apotheke.de's Google search ad spend, ad clicks and cost-per-click. Review performance over time and gain deeper view into their ad campaign spend.
apotheke.de devices
Review apotheke.de's performance across desktop and mobile devices. Analyze how revenue, conversion rate, transactions, AOV and sessions vary depending on the device shoppers use.
